Suhayl Nasr
Psychiatry · Michigan City, INNPI 1891883062
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $618,360 of the $739,305 with a category attached, or 83.6%. 10 manufacturers reported payments, led by AbbVie at 32.0% of the total. Reporting peaked in 2023 at $239,171 and has fallen 73.4% since, to $63,558 in 2024. Among psychiatry clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 712 payments — averaging $1038.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$236K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$172K
- Neurocrine Biosciences, Inc.$124K
- Alkermes, Inc.$66K
- Axsome Therapeutics, Inc.$54K
- Otsuka America Pharmaceutical, Inc.$47K
- plus $40K from 4 others
Across 86 payments — averaging $570.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Livanova USA, Inc.$48K
- Neurocrine Biosciences, Inc.$1K
What the payments were for
- Consulting fees$69,2379%
- Speaking & faculty fees$618,36084%
- Travel & lodging$40,2005%
- Food & beverage$11,5012%
- Education$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 245 | $236,367 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 149 | $171,891 |
| Neurocrine Biosciences, Inc. | 118 | $123,671 |
| Alkermes, Inc. | 60 | $66,366 |
| Axsome Therapeutics, Inc. | 41 | $54,013 |
| Otsuka America Pharmaceutical, Inc. | 53 | $47,492 |
| Teva Pharmaceuticals USA, Inc. | 29 | $24,892 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $8,852 |
| Johnson & Johnson | 6 | $4,712 |
| Sunovion Pharmaceuticals Inc. | 2 | $1,050 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$739,305 in reported general payments places this provider in the 95th percentile of 514 psychiatry providers in Indiana.
Other psychiatry in Michigan City
- Steven PaulCarmel$2.9M
- Jay FawverAngola$1.4M
- Christopher BojrabCarmel$713K
- Joseph FanelliMunster$443K
- Eric JaggersJeffersonville$260K
- Larry LambertsonFort Wayne$208K
- Louis CadyNewburgh$135K
- Charles BeasleyIndianapolis$129K
- Muhammad MunirAnderson$92K
- Prevesh RustagiFort Wayne$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.